Literature DB >> 3905097

Cellular immune response to Mycobacterium bovis (BCG) in genetically-susceptible and resistant congenic mouse strains.

D Bourassa, A Forget, M Pelletier, E Skamene, R Turcotte.   

Abstract

Congenic Bcgr (C.D2, resistant) and Bcgs (BALB/c, susceptible) mice were infected intravenously with Mycobacterium bovis (BCG, strain Montreal) in order to establish the relationship between different indicators of the cell-mediated immune response and the bacterial load attained in the host. There was a correlation between the bacterial burden and the splenomegaly response, granuloma formation in the liver and cross-protection against an heterologous pathogen (Listeria monocytogenes) in Bcgr and Bcgs mice. No relationship was found between bacterial load or granuloma formation and the development of specific acquired protection against an homologous organism (BCG or M. tuberculosis, H37Rv) as assessed by the level of resistance attained in BCG-primed mice challenged with virulent H37Rv or by the adoptive immunity conferred by BCG-primed spleen cells transferred to naïve irradiated recipients challenged with BCG.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905097      PMCID: PMC1577405     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

Review 2.  Granulomatous inflammations.

Authors:  D L Boros
Journal:  Prog Allergy       Date:  1978

3.  Antigen specific lymphocyte transformation, delayed hypersensitivity and protective immunity. I. Kinetics of the response.

Authors:  P J Patel; M J Lefford
Journal:  Cell Immunol       Date:  1978-05       Impact factor: 4.868

4.  Growth of mycobacterium bovis (BCG) in T lymphocyte-depleted mice.

Authors:  F M Collins; C C Congdon; N E Morrison
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

Review 5.  Relation between delayed hypersensitivity and immunity in tuberculosis.

Authors:  G P Youmans
Journal:  Am Rev Respir Dis       Date:  1975-02

6.  Transfer of adoptive immunity to tuberculosis in mice.

Authors:  M J Lefford
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

7.  Histological and immunopathological studies of delayed hypersensitivity reaction to tuberculin in mice.

Authors:  M Pelletier; A Forget; D Bourassa; E Skamene
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

Review 8.  A possible relationship between delayed hypersensitivity and cell-mediated immunity.

Authors:  S B Salvin; R Neta
Journal:  Am Rev Respir Dis       Date:  1975-04

9.  Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

10.  Enhancing effect of passive immunization with mycobacterial antibodies on humoral and cellular immunity in BCG-infected mice.

Authors:  A Forget; R Turcotte; J C Benoit; A G Borduas
Journal:  Ann Immunol (Paris)       Date:  1978 Feb-Mar
View more
  3 in total

Review 1.  Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice.

Authors:  E Buschman; A S Apt; B V Nickonenko; A M Moroz; M H Averbakh; E Skamene
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.

Authors:  O Denis; E Lozes; K Huygen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

3.  Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin.

Authors:  Jason C O'Connor; Caroline André; Yunxia Wang; Marcus A Lawson; Sandra S Szegedi; Jacques Lestage; Nathalie Castanon; Keith W Kelley; Robert Dantzer
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.